Cas:10029-07-9 1,4-Cyclohexanediyldimethanamine manufacturer & supplier

Chemical Name:1,4-Cyclohexanediyldimethanamine

CAS.NO:10029-07-9

Synonyms:trans-1,4-Bis(aminomethyl)cyclohexane;1r-bromo-4t-chloro-cyclohexane;Cyclohexane-1,4-diyldimethanamine;bis-1,4-aminomethylcyclohexane;trans-1,4-cyclohexylenebis(methylamine);trans-1,4-cyclohexanebis(methyamine);trans-1-Brom-4-chlor-cyclohexan;Cyclohexane,1-bromo-4-chloro-,trans;1,4-Cyclohexanedimethanamine, trans-;trans-1,4-Bis-(aminomethyl)-cyclohexan;1,4-Cyclohexanedimethanamine;trans-1,4-Cyclohexanediyldimethanamine;trans-1,4-chlorobromocyclohexane;1,4-Cyclohexanediyldimethanamine;trans-1,4-Bromchlorcyclohexan;trans-Hexahydro-p-xylylenediamine;Cyclohexane,1-bromo-4-chloro;1r-Brom-4t-chlor-cyclohexan

Molecular Formula:C₈H₁₈N₂

Molecular Weight:142.242

HS Code:2921300090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:229.4±8.0 °C at 760 mmHg

Density:0.9±0.1 g/cm3

Index of Refraction:1.478

PSA:52.04000

Exact Mass:142.147003

LogP:0.47

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like trans-1,4-Bis(aminomethyl)cyclohexane chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1r-Brom-4t-chlor-cyclohexan physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,trans-1,4-cyclohexanebis(methyamine) Use and application,trans-1,4-cyclohexylenebis(methylamine) technical grade,usp/ep/jp grade.

Related News: Natural Biogenex, a 100 per cent subsidiary of Natural Capsules, is speeding up its efforts to manufacture active pharmaceutical ingredients (APIs) following the recent grant from Union government’s production linked incentive (PLI) scheme to offset the import dependence. 2,2′-bis-chloromethyl-[3,3′]bithiophenyl manufacturers Charles River Laboratories and AstraZeneca have maintained a strategic partnership since 2012, providing AstraZeneca with outsourced regulated safety and development support on a range of treatments and vaccines, including testing and facilitating the deployment of the vaccines Vaxzevria for COVID-19 and Fluenz for seasonal infleunza. Peptide,(Ser-Val-Thr-Val-His-Ser-Ser-Glu-Pro-Glu-Val-Arg-Ile-Pro-Glu-Asn-Asn-Pro-Val-Lys-Leu-Ser-Cys-Ala-Tyr-Gly-Met-Phe-Gln-Xaa-Pro-Xaa-Ser-Gly) suppliers After the IPO, he now owns a 53% stake, worth $3.1 billion, plus roughly $100 million in cash and other investments, including a winery in northeastern Italy. His sons Franco and Marco (the company’s vice chairman) each own 12% stakes worth about $730 million apiece. N-propargyl-N-(1,3-dioxan-2-ylmethyl)-α-chloroacetamide vendor & factory.